Team
Diversity and Plasticity of Chilhood Tumors (DePiCT)
To top
Team
OLIVIER DELATTRE
Diversity and Plasticity of Chilhood Tumors (DePiCT)
Childhood cancers represent the second cause of death in children in developed countries. Most of these tumors develop from embryonal tissues and constitute, in contrast to adult tumors, accidents of development rather than of tissue renewal or ageing. Different characteristics distinguish childhood from adult cancers and may appear as elements of relative simplicity to study their mechanisms of initiation and progression: the low number of genetic alterations which probably account for a limited role of genetic instability, the low exposure of children to environmental mutagenic factors and the very rapid development of these tumors which suggest a limited number of oncogenic steps.
Members
Image
Image
Image
Image
Key publications
All publications
-
-
-
-
-
-
Transcriptomic definition of molecular subgroups of small round cell sarcomasThe Journal of Pathology
News
All news
-
Promising results from Institut Curie presented at the AACR congressFrom April 5 to 10 2024 in San Diego (United States), the scientific community and medical community will be meeting for the annual congress of the American Association for Cancer Research. This is an opportunity for Institut Curie researchers and doctors to present their advances in the various fields of cancer research.05/04/2024
-
Institut Curie joins global Cancer Grand Challenges team taking on Solid tumors in childrenThe doctor Olivier Delattre, Diversity and plasticity of childhood tumors team leader and director of the research unit Cancer, heterogeneity, instability, and plasticity at Institut Curie, is part of a global, interdisciplinary team of researchers, labeled team KOODAC, that have been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle solid tumors in children.06/03/2024
-
Dr. Olivier Delattre, winner of the Inserm 2022 Grand PrixDr. Olivier Delattre, director of the SIREDO center at Institut Curie and the Research Center’s Cancer, Heterogeneity, Instability and Plasticity Unit, was awarded the Inserm 2022 Grand Prix on December 6, 2022 at the Collège de France in a mark of recognition for the Inserm research director and oncopediatrician’s major discoveries in, and commitment to, pediatric cancer.08/12/2022
-
Cancers de l’enfant : de nouvelles perspectives prometteuses en immunothérapieDes scientifiques de l’Institut Curie, de l’Inserm et du CNRS viennent de mettre en évidence une nouvelle activité d’un facteur de transcription caractéristique du sarcome d’Ewing : celui-ci induit l’expression de gènes hautement spécifiques à la tumeur. Une découverte qui pourrait ouvrir la voie à l’immunothérapie dans les sarcomes, et plus largement dans les tumeurs pédiatriques.11/05/2022